Pineapple gel approved for burns


A topical gel based on pineapple enzymes has been approved in the EU for use in the treatment of burns.

NexoBrid gel from privately owned biotech MediWound, contains proteolytic enzymes from the stem of the pineapple plant. It is the first pharmacological treatment for the removal of scab tissue associated with severe burns, which are typically removed surgically. Removal of scab tissue is essential to speed the healing process and prevent infection.

NexoBrid gel was designated an orphan medicine in 2002. Israeli generics giants Teva paid $163 million to raise its stake in Mediwound from 14% to 51% in 2010, according to Reuters.


Related Content

Alexion to buy Synageva for rare disease drugs

12 May 2015 Business

news image

$8.4bn deal gives firm access to enzyme drug currently under review with US and EU regulators

Traits not technology should govern EU GM laws, MPs say

27 February 2015 News and Analysis

news image

UK science and technology committee says European rules are flawed and need changing

Most Read

Refining Avogadro’s number on way to new kilo

21 July 2015 Research

news image

Most precise value yet reduces uncertainty down to 20 atoms in a billion

Weaving is believing

23 July 2015 The Crucible

news image

Philip Ball unpicks the history of science’s woollen wardrobe

Most Commented

Caramel colour in soft drinks linked to cancer

26 February 2015 News and Analysis

news image

Regulatory bodies and researchers sceptical of study on 4-MEI found in food colour

Weaving is believing

23 July 2015 The Crucible

news image

Philip Ball unpicks the history of science’s woollen wardrobe